Sorry Joe Wolf I should have explained myself better
1. With URB you are quite right that there was a base management fee plus commissions. This is the “double layering” of fees that I was referring to that was certainly an issue. I remember discovering that for the first time on this forum and kicking myself for not picking it up in my reading. So I’m not trying to claim it was a roaring success just provide my different opinion for discussion as I think it’s relevant to the future of SOL
2. The discount I referred to is the gap between the inferred net asset value of BKW and its current share price. I made up a bit of a model breaking this down and posted it in the forum for that stock if you want to take a look but a little over $20 of that asset value is in the SOL shareholding so it could reduce pretty quickly if SOL is indeed a bit overvalued as you point out (I tend to agree on that one and think fair value is between $29 and $30)
- Forums
- ASX - By Stock
- Ann: WHSP 2023 AGM Presentation
SOL
washington h soul pattinson & company limited
Add to My Watchlist
0.00%
!
$41.53

Sorry Joe Wolf I should have explained myself better1. With URB...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$41.53 |
Change
0.000(0.00%) |
Mkt cap ! $15.27B |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 88 | $44.03 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$39.03 | 25 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 85 | 44.030 |
1 | 32 | 42.900 |
1 | 5574 | 42.660 |
1 | 1 | 42.200 |
3 | 110 | 42.000 |
Price($) | Vol. | No. |
---|---|---|
39.030 | 25 | 1 |
39.460 | 65 | 2 |
39.580 | 5 | 1 |
39.910 | 1018 | 3 |
40.420 | 1 | 1 |
Last trade - 09.44am 26/06/2025 (20 minute delay) ? |
Featured News
SOL (ASX) Chart |
Day chart unavailable
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
SPONSORED BY The Market Online